39939-07-6Relevant articles and documents
PCSK9 INHIBITORS AND METHODS OF USE THEREOF
-
Page/Page column 146-147, (2020/07/31)
The invention relates to a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein.
Novel spirocyclic systems via multicomponent aza-Diels-Alder reaction
Llona-Minguez, Sabin,Throup, Adam,Steiner, Emilie,Lightowler, Molly,Van Der Haegen, Sandra,Homan, Evert,Eriksson, Lars,Stenmark, P?l,Jenmalm-Jensen, Annika,Helleday, Thomas
supporting information, p. 7758 - 7764 (2017/10/06)
Here we present a two-step diastereoselective methodology building on a multicomponent aza-Diels-Alder reaction. Using previously unexplored cyclic ketones, heterocyclic amines and cyclopentadiene derivatives, we obtained novel spiro-heterocyclic frameworks at the interphase between drug-like molecules and natural products.
Cis,cis,cis,cis-1,2,3,4,5-Pentakis(hydroxymethyl)cyclopentane
Pujol, Adeline R.,Ratel-Ramond, Nicolas,Gourdon, André
, p. 9139 - 9144 (2013/09/24)
All-cis pentamethanolcyclopentane has been obtained in six steps by Diels-Alder condensation of maleic anhydride with (benzyloxymethyl)cyclopenta-2, 4-diene, reduction of the anhydride to a diol that was protected as the acetonide. Then, ozonolysis of the double bond, followed by reduction led to a cis-diol. Then successive deprotections of the three other methanol groups gave the cis,cis,cis,cis-1,2,3,4,5-pentakis(hydroxymethyl)cyclopentane.